ADXN
Addex Therapeutics Ltd American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Addex Therapeutics (ADXN) Stock: Buy, Sell, or Hold?
$4.06
-1.23 (-23.25%)
▼
5d:
+40.0%
30d:
+53.2%
90d:
-28.65%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (5%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$2.59 – $3.64
Position: EXTENDED
Wall Street Target
$30.00
+638.9% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$2.68 / $6.50
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: ADXN is 11.5% above its trading range ($3.64). While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When ADXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ADXN is currently trading at $4.06, which is considered extended relative to its 30-day fair value range of $2.59 to $3.64.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $2.68, while resistance sits at $6.50. Short-term momentum is weak, with the stock down 23.3% recently.
Market Sentiment: ADXN scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+638.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $2.68, while resistance sits at $6.50. Short-term momentum is weak, with the stock down 23.3% recently.
Market Sentiment: ADXN scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $30.00 (+638.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.59 -
$3.64
Company Quality Score
33/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
5.3%
Trading Range & Key Levels
30-Day Trading Range
$2.59 -
$3.64
Current vs Trading Range
EXTENDED
Support Level
$2.68
Resistance Level
$6.50
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Technical Setup Structure
MONITORING
Absorption:
Inactive (CMF -0.10)
Pullback / Drawdown:
-51.7% from 52W High
Consolidation:
Trending (ADX 34.3)
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+11.5% above its trading range)
- BEARISH: Weak technical setup (23/100)
- BEARISH: Downward momentum (-23.3%)
- BULLISH: Trading 638.9% below Wall St target ($30.00)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Wall Street Target
$30.00
(+638.9%)
Revenue Growth (YoY)
-72.7%
Share ADXN Analysis
Share this live ADXN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 15, 2026 9:17 PM ET
Data refreshes hourly during market hours. Next update: 10:17 PM
Data refreshes hourly during market hours. Next update: 10:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 54 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 45 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 42 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ADXN Research Pages
Part B: Tradestie Flagship Market Scanners